Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives (Q38753775)

6 September 2017

Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives (English)

1 reference

6 September 2017

Li Zhou

1

1 reference

6 September 2017

Kui Wang

2

1 reference

6 September 2017

Qifu Li

3

1 reference

6 September 2017

Edouard C Nice

4

1 reference

6 September 2017

Haiyuan Zhang

5

1 reference

6 September 2017

Canhua Huang

6

1 reference

6 September 2017

27 February 2016

1 reference

Expert Review of Proteomics

6 September 2017

1 reference

6 September 2017

13

1 reference

6 September 2017

367-381

1 reference

6 September 2017

4

1 reference

6 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Clinical proteomics: translating benchside promise into bedside reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Personalizing oncology: perspectives and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

A new initiative on precision medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Rapid learning for precision oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Can we deconstruct cancer, one patient at a time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic workflow for analysis of archival formalin-fixed and paraffin-embedded clinical samples to a depth of 10 000 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

MALDI profiling of human lung cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

The Haptoglobin β chain as a supportive biomarker for human lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Cerebrospinal fluid top-down proteomics evidenced the potential biomarker role of LVV- and VV-hemorphin-7 in posterior cranial fossa pediatric brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mining the malignant ascites proteome for pancreatic cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Toward improving the proteomic analysis of formalin-fixed, paraffin-embedded tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

The potential clinical impact of the tissue-based map of the human proteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Combining laser capture microdissection and proteomics: methodologies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mass spectrometry-based protein biomarker discovery: solving the remaining challenges to reach the promise of clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Advances in human proteomics at high scale with the SOMAscan proteomics platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Unleashing the power of proteomics to develop blood-based cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Glycans in cancer and inflammation--potential for therapeutics and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Advancement of biomarker discovery and validation through the HUPO plasma proteome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Label-free detection techniques for protein microarrays: prospects, merits and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

ssDNA aptamer-based surface plasmon resonance biosensor for the detection of retinol binding protein 4 for the early diagnosis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Label-free immunosensor for prostate-specific antigen based on single-walled carbon nanotube array-modified microelectrodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multiplexed electrical detection of cancer markers with nanowire sensor arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Label-free quantitation of a cancer biomarker in complex media using silicon photonic microring resonators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Label-free biomarker sensing in undiluted serum with suspended microchannel resonators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Human saliva proteome analysis and disease biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Characterization of Listeria monocytogenes recovered from imported cheese contributed to the National PulseNet Database by the U.S. Food and Drug Administration from 2001 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mass spectrometry in high-throughput proteomics: ready for the big time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Application of LC/MS to proteomics studies: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

A targeted proteomics-based pipeline for verification of biomarkers in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomics by FTICR mass spectrometry: top down and bottom up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomics by mass spectrometry: approaches, advances, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

High-throughput proteomics using matrix-assisted laser desorption/ ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

MALDI-TOF MS as evolving cancer diagnostic tool: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Biomarker Characterization by MALDI-TOF/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Application of MALDI-TOF mass spectrometry in screening and diagnostic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

MALDI imaging mass spectrometry: bridging biology and chemistry in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mass spectrometry imaging of biomolecular information

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic analysis of tissue samples in translational breast cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Approaching MALDI molecular imaging for clinical proteomic research: current state and fields of application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

MALDI tissue imaging: from biomarker discovery to clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Imaging mass spectrometry in biomarker discovery and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

MALDI imaging mass spectrometry in cancer research: combining proteomic profiling and histological evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Direct profiling and identification of peptide expression differences in the pancreas of control and ob/ob mice by imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mass spectrometry-based proteomics turns quantitative

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

SILAC-based quantitative proteomic analysis of gastric cancer secretome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Liquid chromatography-mass spectrometry-based quantitative proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Combining bioinformatics and MS-based proteomics: clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Less label, more free: approaches in label-free quantitative mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Detecting differential and correlated protein expression in label-free shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Label-free mass spectrometry-based proteomics for biomarker discovery and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Data standardization and sharing-the work of the HUPO-PSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Spectra, chromatograms, Metadata: mzML-the standard data format for mass spectrometer output

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

The mzQuantML data standard for mass spectrometry-based quantitative studies in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Mass spectrometry-based proteomics in preclinical drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Chemical proteomic strategies for the discovery and development of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

The role of targeted chemical proteomics in pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Application of chemistry-based functional proteomics to screening for novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Chemistry-based functional proteomics for drug target deconvolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Target profiling of small molecules by chemical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

21 January 2018

Targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Dynamic proteomics of individual cancer cells in response to a drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomic analysis of propiconazole responses in mouse liver: comparison of genomic and proteomic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Application of two-dimensional gel-based mass spectrometry to functionally dissect resistance to targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Personal omics profiling reveals dynamic molecular and medical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Genomics, type 2 diabetes, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

A proteomic glimpse into the initial global epigenetic changes during HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Protein Termini and Their Modifications Revealed by Positional Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteolytic post-translational modification of proteins: proteomic tools and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Positional proteomics in the era of the human proteome project on the doorstep of precision medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Integration of molecular pathology, epidemiology and social science for global precision medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Cohort study of fatty acid synthase expression and patient survival in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proceedings of the second international molecular pathological epidemiology (MPE) meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Proteomics analysis in lung cancer: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Targeted In-Gel MRM: A Hypothesis Driven Approach for Colorectal Cancer Biomarker Discovery in Human Feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Murine fecal proteomics: A model system for the detection of potential biomarkers for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

Functional and quantitative proteomics using SILAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

iTRAQ protein quantification: A quality-controlled workflow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2016.1159959

10.1586/14789450.2016.1159959

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference